Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 5, 2008, Pages 624-

  Saitis, Mixalis ^a   Papazisis, Georgios ^a   Katsigiannopoulos, Konstantinos ^a   Kouvelas, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ZIPRASIDONE;

ADULT; AMENORRHEA; BREAST TENDERNESS; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; LETTER; NUCLEAR MAGNETIC RESONANCE; PARANOID SCHIZOPHRENIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; LONG-TERM CARE; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA, PARANOID; SULPIRIDE; THIAZOLES; YOUNG ADULT;

EID: 53149137453     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01859.x     Document Type: Letter

References (9)

1. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003 28 (Suppl. 2 55 68.
2. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinemia: Mechanisms, clinical features and management. Drugs 2004 64 : 2291 2314.
3. Lusskin SI, Cancro R, Chuang L, Jacobson J. Prolactin elevation with ziprasidone. Am. J. Psychiatry 2004 161 : 1925.
4. Anghelescu I, Wolf J. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: A case report. J. Clin. Psychiatry 2004 65 : 1286 1287.
5. Burris KD, Molski TF, Xu C et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 2002 302 : 381 389.
6. Lee BH, Kim YK, Park SH. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006 30 : 714 717.
7. Shim JC, Shin JG, Kelly DL et al. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: A placebo-controlled trial. Am. J. Psychiatry 2007 164 : 1404 1410.
8. Mendhekar DN, Andrade C. Galactorrhea with aripiprazole. Can. J. Psychiatry 2005 50 : 243.
9. Mallikaarjun S, Salazar DE, Bramer SL. Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. J. Clin. Pharmacol. 2004 44 : 179 187.